Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.
The debate over pharmaceutical advertising on television has resurfaced with renewed vigor, among populist conservatives and activists, such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback